Jessica Sachs
CIK 1782545 · Chief Medical Officer · last filed 2025-12-30
Jessica Sachs is a Chief Medical Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $3.2M of COGT on Dec 30, 2025. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.43M
2
12
-$3.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Chief Medical Officer | 133,938 | $33.10 | $4.43M | -$3.20M | 10 | 2025-12-30 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2020-02-13 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-30 | COGT | Sell (S) | −82,642 | -$3.20M | EDGAR |
| 2025-12-19 | COGT | Mixed | +215,284 | -$6.10M | EDGAR |
| 2025-01-27 | COGT | Grant (A) | — | $0 | EDGAR |
| 2024-01-25 | COGT | Grant (A) | — | $0 | EDGAR |
| 2023-02-15 | COGT | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | COGT | Grant (A) | +622 | $4.6K | EDGAR |
| 2022-01-27 | COGT | Grant (A) | — | $0 | EDGAR |
| 2022-01-04 | COGT | Grant (A) | +674 | $4.6K | EDGAR |
| 2021-02-12 | COGT | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | COGT | Grant (A) | — | $0 | EDGAR |